Details of the Drug Pharmacogenomic Perturbation Atlas
General Information of Drug (ID: DMZ2LGD)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms |
Pramoxine hydrochloride; 637-58-1; Pramoxine HCl; Pramocaine hydrochloride; Prax Lotion; Tronolane; Tronothane hydrochloride; ProctoFoam-NS; Pramocaine (hydrochloride); UNII-88AYB867L5; HSDB 7220; EINECS 211-293-1; NSC 25573; Pramoxine hydrochloride [USP]; MLS000028604; Morpholine, 4-[3-(4-butoxyphenoxy)propyl]-, hydrochloride; 88AYB867L5; 4-(3-(p-Butoxyphenoxy)propyl)morpholine hydrochloride; p-Butoxyphenyl gamma-morpholinopropyl ether hydrochloride; gamma-Morpholinopropyl 4-n-butoxyphenyl ether hydrochloride; SMR000058670
| |||||
| Cross-matching ID | ||||||
Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)
|
|
|||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
Pharmacogenomic Perturbation Across Diseases and Tissues
|
Bone
Osteosarcoma
Breast
Breast adenocarcinoma
Prostate
Prostate carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
